MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Institutional Ownership and Insiders Activity
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) is widely held by institutional investors, with 164 firms reporting positions valued at approximately $751.56M based on SEC Form 13F filings for the quarter ended September 30, 2026.
Bvf Inc/Il is the largest disclosed holder, reporting approximately $187.22M in MLTX holdings in its latest filing.
Institutional Holders
164
Total Reported Value
$751.56M
Largest Holder
Bvf Inc/Il
Largest Position
$187.22M
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
41
Funds Exiting Positions
18
Top Institutional Owners
View allInvestorReported Balance
- Bvf Inc/Il$187.22M
- Deep Track Capital, Lp$94.83M
- D. E. Shaw & Co., Inc.$40.80M
- Cormorant Asset Management, Lp$33.41M
- Weiss Asset Management Lp$27.39M
MLTX News
All news- Great Point Partners Llc Investment Activity in Q2 2026: Focus on Biotech and Pharma Stocks
Aug 19, 2026 · valut.ai
- BVF Inc IL Portfolio Activity in Q2 2026
Aug 18, 2026 · valut.ai
Related MLTX Institutional Insights:
- MLTX 13F Institutional Holders
- MLTX Superinvestors
- MLTX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MLTX Insider Trading & SEC Form 4 Activity
- MLTX Articles
- Top Institutional Investor Stock Rankings